The present invention is directed to a polypeptide which comprises: (i) an Rv2386c protein sequence (ii) a variant of an Rv2386c protein sequence of (iii) an immunogenic fragment of an Rv2386c protein sequence. In other aspects the invention is directed to associated polynucleotides, fusion proteins and methods for the treatment or prevention of tuberculosis.